Journal Of Clinical Oncology

Journal Of Clinical Oncology

临床肿瘤学杂志

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Journal Of Clinical Oncology》是由American Society of Clinical Oncology出版社于1983年创办的英文国际期刊(ISSN: 0732-183X,E-ISSN: 1527-7755),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.1673...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比96.87%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在479篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Clinical Oncology审稿周期约为 约2月 。该刊近年未被列入国际预警名单,年发文量约479篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 479 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 6 / 322

98.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 8 / 322

97.67%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:41.2 SJR:10.639 SNIP:6.162
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 9 / 404

97%

大类:Medicine 小类:Cancer Research Q1 6 / 230

97%

期刊发文

  • Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)

    Author: Peng, Zhenwei; Fan, Wenzhe; Zhu, Bowen; Wang, Guoying; Sun, Junhui; Xiao, Chengjiang; Huang, Fuxi; Tang, Rong; Cheng, Yu; Huang, Zhen; Liang, Yuchuang; Fan, Huishuang; Qiao, Liangliang; Li, Fuliang; Zhuang, Wenquan; Peng, Baogang; Wang, Jiping; Li, Jiaping; Kuang, Ming

    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 1, pp. 117-+. DOI: 10.1200/JCO.22.00392

  • Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

    Author: Zhang, Haiyan; Fan, Zhiping; Huang, Fen; Han, Lijie; Xu, Yajing; Xu, Na; Deng, Lan; Wang, Shunqing; Lin, Dongjun; Luo, Xiaodan; Zhang, Qing; Liu, Xiaodan; Li, Xudong; Liang, Xinquan; Xie, Shuangfeng; Qu, Hong; Yu, Sijian; Zhou, Hongsheng; Shi, Pengcheng; Xuan, Li; Lin, Ren; Liu, Hui; Jin, Hua; Sun, Jing; Liu, Qifa

    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 343-+. DOI: 10.1200/JCO.22.00767

  • Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

    Author: Drilon, Alexander; Subbiah, Vivek; Gautschi, Oliver; Tomasini, Pascale; de Braud, Filippo; Solomon, Benjamin J.; Tan, Daniel Shao-Weng; Alonso, Guzman; Wolf, Juergen; Park, Keunchil; Goto, Koichi; Soldatenkova, Victoria; Szymczak, Sylwia; Barker, Scott S.; Puri, Tarun; Bence Lin, Aimee; Loong, Herbert; Besse, Benjamin

    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 385-+. DOI: 10.1200/JCO.22.00393

  • Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

    Author: Wang, Zhijie; Wu, Lin; Li, Baolan; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, Xiaoli; Hu, Sheng; Zhang, Wei; Wang, Qiming; Jia, Yuming; Wang, Ziping; Song, Yong; Wu, Jingxun; Shi, Meiqi; Li, Xingya; Han, Zhigang; Liu, Yunpeng; Yu, Zhuang; Liu, An-Wen; Wang, Xiuwen; Zhou, Caicun; Zhong, Diansheng; Miao, Liyun; Zhang, Zhihong; Zhao, Hui; Yang, Jun; Wang, Dong; Wang, Yingyi; Li, Qiang; Zhang, Xiaodong; Ji, Mei; Yang, Zhenzhou; Cui, Jiuwei; Gao, Beili; Wang, Buhai; Liu, Hu; Nie, Lei; He, Mei; Jin, Shi; Gu, Wei; Shu, Yongqian; Zhou, Tong; Feng, Jian; Yang, Xinmei; Huang, Cheng; Zhu, Bo; Yao, Yu; Tang, Xiongwen; Yu, Jianjun; Maher, Ellen; Feng, Hui; Yao, Sheng; Keegan, Patricia; Wang, Jie

    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 3, pp. 651-+. DOI: 10.1200/JCO.22.00727

  • BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers

    Author: Sun, Jie; Chu, Futao; Pan, Jiani; Zhang, Yaxin; Yao, Lu; Chen, Jiuan; Hu, Li; Zhang, Juan; Xu, Ye; Wang, Xiaojia; Cao, Wenming; Xie, Yuntao

    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 5, pp. 991-+. DOI: 10.1200/JCO.22.00833

  • Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial

    Author: Hillmen, Peter; Eichhorst, Barbara; Brown, Jennifer R.; Lamanna, Nicole; O'Brien, Susan M.; Tam, Constantine S.; Qiu, Lugui; Kazmierczak, Maciej; Zhou, Keshu; Simkovic, Martin; Mayer, Jiri; Gillespie-Twardy, Amanda; Shadman, Mazyar; Ferrajoli, Alessandra; Ganly, Peter S.; Weinkove, Robert; Grosicki, Sebastian; Mital, Andrzej; Robak, Tadeusz; Osterborg, Anders; Yimer, Habte A.; Salmi, Tommi; Ji, Meng; Yecies, Jessica; Idoine, Adam; Wu, Kenneth; Huang, Jane; Jurczak, Wojciech

    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 5, pp. 1035-+. DOI: 10.1200/JCO.22.00510

  • Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial

    Author: Qin, Shukui; Chen, Zhendong; Fang, Weijia; Ren, Zhenggang; Xu, Ruocai; Ryoo, Baek-Yeol; Meng, Zhiqiang; Bai, Yuxian; Chen, Xiaoming; Liu, Xiufeng; Xiao, Juxiang; Ho, Gwo Fuang; Mao, Yimin; Wang, Xin; Ying, Jieer; Li, Jianfeng; Zhong, Wenyan; Zhou, Yu; Siegel, Abby B.; Hao, Chunyi

    Journal: JOURNAL OF CLINICAL ONCOLOGY. 2023; Vol. 41, Issue 7, pp. 1434-+. DOI: 10.1200/JCO.22.00620

  • Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial.

    Author: Jiang J1, Li Y1, Shen Q1,2, Rong X1, Huang X1, Li H1, Zhou L3, Mai HQ4, Zheng D5, Chen MY4, Xu Y1, Li J4, Hui X6, Simone CB 2nd7, Gaertner J8, Argyriou AA9, Chow E10, Chen P3, Tang Y1.

    Journal: J Clin Oncol. 2019 Jan 10;37(2):135-143. doi: 10.1200/JCO.18.00896. Epub 2018 Nov 20.